← Evidence map

ReviewJournal of gynecologic oncology2022

Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective.

Ning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36335989